COSCIENS Biopharma Inc. Research and Development Expense
COSCIENS Biopharma Inc. (CSCIF) reported Research and Development Expense of $2.95 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-25
- COSCIENS Biopharma Inc. research and development expense for the quarter ending 2025-12-31 was $599.00K, a 79.44% decline year-over-year.
- COSCIENS Biopharma Inc. research and development expense for the quarter ending 2025-09-30 was $527.00K, a 81.17% decline year-over-year.
- COSCIENS Biopharma Inc. research and development expense for the quarter ending 2025-06-30 was $690.00K, a 54.90% decline year-over-year.
- COSCIENS Biopharma Inc. research and development expense for the quarter ending 2025-03-31 was $1.13M, a 6.78% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 9 month | Research And Development Expense 9 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $599.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $1.13M derived: sum of 2 quarters · filed 2026-03-25 | $1.82M derived: sum of 3 quarters · filed 2026-03-25 | $2.95M 20-F · filed 2026-03-25 | ||||
| 2025-09-30 | $527.00K 6-K · filed 2025-11-12 | $1.22M derived: sum of 2 quarters · filed 2025-11-12 | $2.35M 6-K · filed 2025-11-12 | $5.26M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-06-30 | $690.00K 6-K · filed 2025-08-14 | $1.82M 6-K · filed 2025-08-14 | $4.74M derived: sum of 3 quarters · filed 2026-03-25 | $7.54M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-03-31 | $1.13M 6-K · filed 2025-05-13 | $4.05M derived: sum of 2 quarters · filed 2026-03-25 | $6.85M derived: sum of 3 quarters · filed 2026-03-25 | $8.38M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | $2.91M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $5.71M derived: sum of 2 quarters · filed 2026-03-25 | $7.24M derived: sum of 3 quarters · filed 2026-03-25 | $8.30M 20-F · filed 2026-03-25 | ||||
| 2024-09-30 | $2.80M 6-K · filed 2025-11-12 | $4.33M derived: sum of 2 quarters · filed 2025-11-12 | $5.39M 6-K · filed 2025-11-12 | $5.88M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $1.53M 6-K · filed 2025-08-14 | $2.59M 6-K · filed 2025-08-14 | $3.08M derived: sum of 3 quarters · filed 2026-03-25 | $3.52M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | $1.06M 6-K · filed 2025-05-13 | $2.58M 6-K · filed 2024-05-16 | $1.55M derived: sum of 2 quarters · filed 2026-03-25 | $1.99M derived: sum of 3 quarters · filed 2026-03-25 | $2.68M derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2023-12-31 | $489.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $925.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.62M derived: sum of 3 quarters · filed 2026-03-25 | $2.04M 20-F · filed 2026-03-25 | $13.56M 20-F · filed 2024-03-27 | |||
| 2023-09-30 | $436.00K 6-K · filed 2024-11-12 | $2.75M 6-K · filed 2023-11-09 | $1.13M derived: sum of 2 quarters · filed 2024-11-12 | $1.55M 6-K · filed 2024-11-12 | $9.69M 6-K · filed 2023-11-09 | -$1.57M derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-06-30 | $691.00K 6-K · filed 2024-08-13 | $2.93M 6-K · filed 2023-08-09 | $1.11M 6-K · filed 2024-08-13 | $6.94M 6-K · filed 2023-08-09 | -$2.01M derived: sum of 3 quarters · filed 2025-04-09 | $1.29M derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-03-31 | $4.01M 6-K · filed 2024-05-16 | -$2.70M derived: sum of 2 quarters · filed 2025-04-09 | $595.00K derived: sum of 3 quarters · filed 2025-04-09 | $2.99M derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2022-12-31 | -$6.71M derived: 20-F 12 month − 6-K 9 month · filed 2025-04-09 | -$3.42M derived: sum of 2 quarters · filed 2025-04-09 | -$1.02M derived: sum of 3 quarters · filed 2025-04-09 | $1.37M 20-F · filed 2025-04-09 | $12.51M 20-F · filed 2023-03-23 | |||
| 2022-09-30 | $3.29M 6-K · filed 2023-11-09 | $5.69M derived: sum of 2 quarters · filed 2023-11-09 | $8.08M 6-K · filed 2023-11-09 | $9.94M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-06-30 | $2.40M 6-K · filed 2023-08-09 | $4.79M 6-K · filed 2023-08-09 | $6.65M derived: sum of 3 quarters · filed 2024-07-17 | $8.14M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-03-31 | $2.39M 6-K · filed 2023-05-09 | $4.25M derived: sum of 2 quarters · filed 2024-07-17 | $5.74M derived: sum of 3 quarters · filed 2024-07-17 | $7.51M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2021-12-31 | $1.86M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $3.35M derived: sum of 2 quarters · filed 2024-07-17 | $5.12M derived: sum of 3 quarters · filed 2024-07-17 | $6.57M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | $1.49M 6-K · filed 2022-11-03 | $801.00K 6-K · filed 2021-11-04 | $3.25M derived: sum of 2 quarters · filed 2022-11-03 | $4.71M 6-K · filed 2022-11-03 | $1.90M 6-K · filed 2021-11-04 | $5.34M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2021-06-30 | $1.77M 6-K/A · filed 2022-08-04 | $738.00K 6-K · filed 2021-08-05 | $3.23M 6-K/A · filed 2022-08-04 | $1.10M 6-K · filed 2021-08-05 | $3.85M derived: sum of 3 quarters · filed 2024-02-15 | $4.22M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2021-03-31 | $1.46M 6-K · filed 2022-05-11 | $363.00K 6-K · filed 2021-05-05 | $2.08M derived: sum of 2 quarters · filed 2024-02-15 | $2.46M derived: sum of 3 quarters · filed 2024-02-15 | $2.65M derived: sum of 4 quarters · filed 2024-02-15 | |||
| 2020-12-31 | $626.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | $998.00K derived: sum of 2 quarters · filed 2024-02-15 | $1.19M derived: sum of 3 quarters · filed 2024-02-15 | $1.51M 20-F/A · filed 2024-02-15 | ||||
| 2020-09-30 | $372.00K 6-K · filed 2021-11-04 | $561.00K derived: sum of 2 quarters · filed 2021-11-04 | $880.00K 6-K · filed 2021-11-04 | $1.14M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-06-30 | $189.00K 6-K · filed 2021-08-05 | $508.00K 6-K · filed 2021-08-05 | $771.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.25M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-03-31 | $319.00K 6-K · filed 2021-05-05 | $582.00K derived: sum of 2 quarters · filed 2022-03-29 | $1.06M derived: sum of 3 quarters · filed 2022-03-29 | $1.63M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | $263.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $738.00K derived: sum of 2 quarters · filed 2022-03-29 | $1.31M derived: sum of 3 quarters · filed 2022-03-29 | $1.84M 20-F · filed 2022-03-29 | ||||
| 2019-09-30 | $475.00K 6-K · filed 2020-11-05 | $1.05M derived: sum of 2 quarters · filed 2020-11-05 | $1.57M 6-K · filed 2020-11-05 | $2.34M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $571.00K 6-K · filed 2020-08-06 | $1.10M 6-K · filed 2020-08-06 | $1.87M derived: sum of 3 quarters · filed 2020-08-06 | $2.22M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $528.00K 6-K/A · filed 2020-05-11 | $1.29M derived: sum of 2 quarters · filed 2020-05-11 | $1.65M derived: sum of 3 quarters · filed 2020-05-11 | $2.63M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $767.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | $1.13M derived: sum of 2 quarters · filed 2020-03-31 | $2.10M derived: sum of 3 quarters · filed 2020-03-31 | $2.93M 20-F · filed 2020-03-31 | ||||
| 2018-09-30 | $358.00K 6-K · filed 2019-11-07 | $1.33M derived: sum of 2 quarters · filed 2019-11-07 | $2.17M 6-K · filed 2019-11-07 | |||||
| 2018-06-30 | $974.00K 6-K · filed 2019-08-13 | $1.81M 6-K · filed 2019-08-13 | ||||||
| 2017-12-31 | $10.70M 20-F · filed 2020-03-31 | |||||||
| 2016-12-31 | $16.50M 20-F · filed 2019-04-01 | |||||||
| 2015-12-31 | $17.23M 20-F · filed 2018-03-28 |